37 verified PDFs
This white paper describes the approaches that researchers have taken in measuring novelty in drug innovation, and then describes a new method involving ...
This white paper arises from two workshops held at the NIH in 2008 and ... drug discovery and drug action should be interwoven into these areas. A case ...
Existing research has overwhelmingly found that when generic drugs enter the market, prices fall substantially, with prices falling to as low as ...
The use of brief intervention and brief therapy techniques has become an increasingly important part of the continuum of care in the treatment of substance ...
Benzimidazole compounds have emerged as versatile and promising entities in medicinal chemistry, with their various pharmacological activity and ...
The task of Brief Therapy is to help clients do something different, by changing their interactive behavior and/or their interpretation of behavior and ...
For drug discovery projects, it is essential to have accurate compound bioactivity and property data to base decisions on for the selection of hits. This is ...
Here, we present the approach taken by Thermo Fisher Scientific and Schrödinger research teams that deployed GeneArt Gene-to-Protein, Thermo · Scientific SPA ...
Streamlined path for developing and deploying AI-powered drug discovery applications. • Pretrained state-of-the-art biomolecular models. • Access to NVIDIA AI ...
Emerging trends in medicinal chemistry: Biologics, nanomedicine, and drug delivery. In addition to small molecule drugs, medicinal chemistry ...
Medicinal chemistry has evolved significantly over the decades, driven by advancements in technology, computational modelling, and understanding ...
The committee concluded that by aligning public and private reimbursement policies with therapeutic value, greater innovation would occur in therapeutic areas ...
Library of Congress Cataloging-in-Publication Data. Foye's principles of medicinal chemistry / edited by Thomas L. Lemke, David A. Williams ; associate.
The aim of creating a therapeutic model is to significantly improve outcomes for the service users, the organization, and all stakeholders. This is achieved ...
Patient-focused drug development or other stakeholder meeting summary reports. Observational survey studies designed to capture patient experience data.
“The goal of Reaxys Medicinal Chemistry is to facilitate the development of 'smarter leads' – leads with optimal affinity, selectivity and ADMET properties; ...
No previous knowledge of biology is assumed and the first six chapters cover the basics of cell structure, proteins, and nucleic acids as applied to drug design ...
